Research Study

A Phase 2 Placebo-Controlled, Double-Blind, Enriched Enrollment Randomized Withdrawal Study to Evaluate the Efficacy and Safety of BIIB074 in Treating Pain Experienced by Subjects With Confirmed Small Fibre Neuropathy That is Idiopathic or Associated With Diabetes Mellitus
Principal Investigator 
Kristine Chapman

Overview

ClinicalTrials.gov# 
NCT03339336
Status 
Recruiting
Study Start/End 
Oct 24, 2018 to Aug 31, 2019
Locations 
Diamond Health Care Centre
Name/Title 
Deborah Kraus, Research Nurse
Phone 
604-875-4111 ext.22950
Email Address 
deborah.kraus@vch.ca
Purpose of Study 

The purpose of this study is to evaluate the efficacy of BIIB074 in treating pain experienced by participants with confirmed small fibre neuropathy (SFN) that is idiopathic or associated with diabetes mellitus.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.